BioPlus Acquisition Corp (BIOS)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Ross Haghighat
Employees:
2
260 MADISON AVENUE, SUITE 800, NEW YORK, NY 10016
2122874092

BioPlus Acquisition Corp. focuses on effecting merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Data derived from most recent annual or quarterly report
Market Cap 147.069 Million Shares Outstanding13.617 Million Avg 30-day Volume 10.889 Thousand
P/E Ratio66.8243 Dividend Yield0.0 EPS0.02
Price to Revenue0.0 Debt to Equity0.0222 EBITDA-1.139 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value551.333 Million
Current Ratio0.638 EPS Growth0 Quick Ratio0.051
1 Yr BETA -0.0036 52-week High/Low 11.68 / 10.05 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM-932.276 Thousand
Altman Z-Score11.7402
View SEC Filings from BIOS instead.

View recent insider trading info

BioPlus Acquisition Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BIOS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIOS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIOPLUS SPONSOR LLC

EXPLORER PARENT LLC

FOUNDER HOLDINGS LLC

VIEUX ALEX SERGE

FLETCHER STEVEN C.

  • 10% Owner
 6,629,999 2023-06-05 1

SHERWIN STEPHEN A

  • Director
 0 2021-12-02 0

LANGE LOUIS G

  • Director
 0 2021-12-02 0

RIGBY JONATHAN CHIEF BUSINESS OFFICER

  • Officer
  • Director
 0 2021-12-02 0

EASTMAN RONALD W

  • Director
 0 2021-12-02 0

HAGHIGHAT ROSS CEO AND CFO

  • Officer
  • Director
 0 2021-12-02 0

CROSS SHAWN

  • Director
 0 2021-12-02 0

GIOVANNETTI GLEN

  • Director
 0 2021-12-02 0

COLISEUM CAPITAL MANAGEMENT, LLC

SHACKELTON CHRISTOPHER S

COLISEUM CAPITAL, LLC

COLISEUM CAPITAL PARTNERS, L.P.

COLISEUM CAPITAL PARTNERS II, L.P.

GRAY ADAM

  • FORMER DIRECTOR & 10% OWNERFORMER DIRECTOR & 10% OWNERFORMER DIRECTOR & 10% OWNERFORMER DIRECTOR & 10% OWNERFORMER DIRECTOR & 10% OWNERFORMER DIRECTOR & 10% OWNER
 No longer subject to file 2019-08-06 0

GREENLEAF DANIEL E CHIEF EXECUTIVE OFFICER

  • Officer
 31,000 2017-11-10 0

DEITSCH STEPHEN CHIEF FINANCIAL OFFICER

  • Officer
 45,211 2017-11-09 0

KREGER JEFFREY M CHIEF FINANCIAL OFFICER

  • Officer
 22,628 2016-11-11 0

PATE R CARTER

  • Director
 84,000 2016-11-10 0

GOLDSTEIN MICHAEL

  • Director
 25,000 2016-06-17 0

GOLDING DAVID W

  • Director
 42,500 2016-06-17 0

BRONFEIN MICHAEL G

  • Director
 80,000 2016-06-17 0

SMITH RICHARD M PRESIDENT AND CEO

  • Officer
  • Director
 135,000 2015-03-16 0

JORDEN YON

  • Director
 20,000 2015-03-12 0

KOHLBERG MANAGEMENT V, LLC

KOHLBERG OFFSHORE INVESTORS V L P

KOHLBERG TE INVESTORS V L P

KOHLBERG INVESTORS V L P

KOHLBERG PARTNERS V, L.P.

KOCO INVESTORS V, L.P.

  • 10% Owner
  • * SEE REMARKS BELOW
No longer subject to file 2013-08-19 0

FRIEDMAN RICHARD H

  • Director
 1,057,565 2012-04-03 0

SAMUELS STUART A

  • Director
 106,300 2011-11-18 0

HUBERS DAVID R

  • Director
 201,700 2010-12-10 0

SARACCO MICHAEL SVP, SPECIALTY SERVICES

  • Officer
 70,000 2010-08-06 0

POSNER BARRY A EXECUTIVE VICE PRESIDENT

  • Officer
 578,138 2010-08-05 0

ROSENBAUM STANLEY CHIEF FINANCIAL OFFICER

  • Officer
 545,041 2010-08-05 0

NASGOVITZ WILLIAM J

  • 10% Owner
 800,000 2009-04-30 0

SCHELHAMMER STEVEN KARL

  • Director
 63,500 2009-03-06 0

ROBBINS RICHARD L

  • Director
 83,500 2008-05-13 0

CORVESE RUSSEL J VICE PRESIDENT MAIL OPERATIONS

  • Officer
 255,987 2006-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 22:15:03 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 21:45:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 21:15:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 20:45:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 20:15:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 19:45:03 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 19:15:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 18:45:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 18:15:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 17:45:06 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 17:15:03 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 16:45:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 15:30:03 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 15:15:04 UTC -6.1245 11.4445 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 14:45:03 UTC 0.0 0.0 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 14:15:04 UTC 0.0 0.0 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 13:45:03 UTC -24.9333 30.2533 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 13:15:04 UTC -24.9333 30.2533 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-06 12:45:05 UTC -24.9333 30.2533 550000
BIOPLUS ACQUISITION CORP-A BIOS 2023-10-05 22:15:04 UTC -24.9333 30.2533 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments